Fred Hassan, Director at BridgeBio Pharma, Inc. (BBIO), bought 19,300 shares at $14.17 ($273K) on 2021-12-29, disclosed to the SEC on 2022-01-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| AMGN | BUY | 2015-08-20 | $502K | — | Filing → |
| VRX | BUY | 2013-09-03 | $5.0M | — | Filing → |
| TWX | BUY | 2010-03-04 | $1.0M | — | Filing → |